Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Phenotype C0948303|peritoneal carcinoma
Sentences 3
PubMedID- 24699008 Methods: we generated peritoneal carcinomatosis and subcutaneous xenografts of colorectal cancer ht29, breast cancer mda-mb-231, and non-small cell lung cancer a549 cell lines in nude mice.
PubMedID- 23758908 Moreover, the approval by the european union in 2009 of the epcam-specific antibody catumaxomab, adds a therapeutic option also in breast cancer patients with peritoneal carcinomatosis and malignant ascites [16].
PubMedID- 22927770 However, in 2011, pietzner et al described a case of successful retreatment with catumaxomab for the management of malignant ascites.60 a 74-year-old female patient with breast cancer and ascites associated with peritoneal carcinomatosis was treated with catumaxomab, with resolution of her symptoms.

Page: 1